Pulike Biological Engineering

Pulike Biological Engineering R&D per Employee

The R&D Spending per Employee of Pulike Biological Engineering (603566.SS) as of Oct 18, 2026 is 58,005.80 CNY. In the previous year, R&D Spending per Employee was 65,916.84 CNY — a change of -12.00% (lower).

R&D per Employee

58,005.80CNY

YoY

-12.00%

Last updated:

R&D Spending per Employee of Pulike Biological Engineering is 2025 58,005.80 CNY. R&D Spending per Employee of Pulike Biological Engineering was 2024 65,916.84 CNY. It decreases by -12.00% lower compared to the previous year.

The Pulike Biological Engineering R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
42,759.58 CNY
Jan 1, 2019
52,860.96 CNY
Jan 1, 2020
66,843.37 CNY
Jan 1, 2021
48,270.27 CNY
Jan 1, 2022
53,914.27 CNY
Jan 1, 2023
58,844.99 CNY
Jan 1, 2024
65,916.84 CNY
Jan 1, 2025
58,005.80 CNY
The Pulike Biological Engineering R&D per Employee history
YEARR&D per EmployeeYoY
58,005.80CNY-12.00%
65,916.84CNY+12.02%
58,844.99CNY+9.15%
53,914.27CNY+11.69%
48,270.27CNY-27.79%
66,843.37CNY+26.45%
52,860.96CNY+23.62%
42,759.58CNY+20.02%
35,628.24CNY+4.70%
34,028.70CNY+39.98%
24,310.12CNY+13.27%
21,462.84CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc, listed on the Shanghai Stock Exchange with ticker 603566.SS and ISIN CNE1000025N0, is a pharmaceutical company based in Luoyang, China. The company went public on May 18, 2015. It employs 1,718 people and operates within the healthcare sector, specifically in the pharmaceuticals industry. Pulike Biological Engineering focuses on the research, development, manufacturing, and sale of biological products for animals, chemical drugs, and Chinese veterinary drugs. The company's veterinary biological products include vaccines and antibodies, which are used for the prevention and control of infectious diseases in poultry and livestock. Its veterinary chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. The company is headquartered in Luoyang, Henan, and its website is http://www.pulike.com.cn/. Pulike Biological Engineering Inc is engaged in the research, development, production, and distribution of veterinary biological products and chemical medicines. The firm's product portfolio targets the prevention and treatment of diseases in animals, with a focus on poultry and livestock health management. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulike Biological Engineering stock

R&D Spending per Employee of Pulike Biological Engineering is 58,005.80 CNY in 2025.

R&D Spending per Employee of Pulike Biological Engineering changed from 65,916.84 CNY to 58,005.80 CNY, representing a -12.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Pulike Biological Engineering historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Pulike Biological Engineering

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Pulike Biological Engineering